David M. Ross
Works:
- Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
- A novel in vitro model of the bone marrow microenvironment in acute myeloid leukemia identifies CD44 and focal adhesion kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance
- Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study